FCX vs NAMSW
Freeport-McMoran Copper & Gold Inc (FCX) versus NewAmsterdam Pharma Company N.V. Warrant (NAMSW) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
Latest reported FCX revenue for 2026-06-30 was $13.26B. Net income was $1.86B. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
NAMSW does not have a complete income-statement cache yet.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. NAMSW currently screens at market cap $0.
Not investment advice. Open the FCX and NAMSW stock pages for the full models.
Not investment advice.